Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
- Principal Investigator
- by Greg Moran, MD (ucla)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Health
- Greg Moran, MD (ucla)
Professor of Clinical , Emergency Medicine. Authored (or co-authored) 133 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- I-Mab Biopharma Co. Ltd.
- ID
- NCT04341116
- Phase
- Phase 2/3
- Study Type
- Interventional
- Last Updated